Skip to main content
GPManual/Blog/
Infectious Diseases13 min readUpdated 10 April 2026

Antibiotic Prescribing in General Practice: A Stewardship Guide

Reducing resistance while treating infections effectively — evidence-based protocols for common GP presentations

Dr. Priya Nair
Dr. Priya Nair
GP & Antimicrobial Stewardship Lead
Published 5 April 2025
Antibiotic Prescribing in General Practice: A Stewardship Guide

Antimicrobial resistance is one of the greatest threats to global health. GPs prescribe approximately 80% of all antibiotics in the UK. This guide covers evidence-based prescribing for the most common GP infections — RTIs, UTIs, skin infections, and ear/throat conditions — with NICE-aligned protocols.

Clinical Decision Support: This article is for educational purposes and supports — not replaces — clinical judgment. Always verify with current national guidelines, BNF, and specialist consultation when needed.

Antimicrobial resistance (AMR) is projected to cause 10 million deaths annually by 2050 if current trends continue. General practitioners prescribe approximately 80% of all antibiotics in the UK, making primary care the most important setting for stewardship interventions. The challenge is balancing the real risk of undertreating serious infections against the population-level harm of overprescribing.

The No-Antibiotic and Delayed Prescribing Strategies

For many common infections, antibiotics provide minimal benefit while contributing to resistance, side effects, and medicalisation of self-limiting illness. The delayed prescribing strategy — giving a prescription to be filled only if symptoms worsen or do not improve within a specified timeframe — has been shown to reduce antibiotic use by 25–40% without increasing complication rates.

ConditionAntibiotic BenefitRecommended Strategy
Acute otitis media (>2 years, mild)Minimal — NNT ~15 for pain reliefNo antibiotic or delayed 72h
Acute sore throat (FeverPAIN 0–1)NoneNo antibiotic
Acute sore throat (FeverPAIN 4–5)Modest — NNT ~5 for symptom durationImmediate or delayed 48h
Acute sinusitis (<10 days)MinimalNo antibiotic or delayed 7 days
Acute cough/LRTI (no pneumonia)None for mostNo antibiotic; consider delayed
Uncomplicated UTI (women)SignificantImmediate antibiotic

Urinary Tract Infections

Uncomplicated UTI in Non-Pregnant Women

  • First-line: Nitrofurantoin 100 mg MR BD for 3 days (avoid if eGFR <30)
  • Alternative: Trimethoprim 200 mg BD for 3 days (avoid if local resistance >20% or used in last 3 months)
  • Do not routinely send MSU before treating uncomplicated UTI in women
  • Send MSU if: treatment failure, recurrent UTI, pregnant, catheterised, or atypical symptoms

UTI in Men

UTI in men is considered complicated and warrants a 7-day course of antibiotics. Always send MSU before treatment. Consider prostatitis if perineal pain, dysuria, and fever — treat with ciprofloxacin or trimethoprim for 28 days. Refer if recurrent UTI in men to exclude structural abnormality.

Catheter-Associated UTI (CAUTI)

Do not treat asymptomatic bacteriuria in catheterised patients — this is not a UTI and antibiotic treatment increases resistance without clinical benefit. Only treat if symptomatic (fever, rigors, new confusion, loin pain, haematuria).

Respiratory Tract Infections

Community-Acquired Pneumonia: CURB-65 Scoring

CURB-65 ScoreMortality RiskManagement
0–1Low (<3%)Treat at home; amoxicillin 500 mg TDS for 5 days
2Intermediate (9%)Consider hospital admission; amoxicillin + clarithromycin
3–5High (15–40%)Urgent hospital admission; IV antibiotics

Sore Throat: FeverPAIN Score

  • Fever >38°C in last 24h: 1 point
  • Purulence on tonsils: 1 point
  • Attend rapidly (within 3 days of onset): 1 point
  • Severely inflamed tonsils: 1 point
  • No cough or coryza: 1 point
  • Score 0–1: No antibiotic; Score 2–3: Delayed 48h; Score 4–5: Immediate phenoxymethylpenicillin 500 mg QDS for 5–10 days

Skin and Soft Tissue Infections

  • Impetigo (localised): Hydrogen peroxide 1% cream or fusidic acid 2% cream for 5 days
  • Impetigo (widespread/systemic): Flucloxacillin 500 mg QDS for 5 days
  • Cellulitis (non-purulent): Flucloxacillin 500 mg QDS for 5–7 days; clarithromycin if penicillin allergy
  • Cellulitis (purulent/abscess): Consider MRSA — send swab; co-amoxiclav or doxycycline
  • Erysipelas: Phenoxymethylpenicillin 500 mg QDS for 5–7 days

Key Clinical Takeaways

  • Use delayed prescribing for most RTIs and mild ENT infections — reduces antibiotic use by 25–40%
  • Nitrofurantoin 100 mg MR BD for 3 days is first-line for uncomplicated UTI in women
  • CURB-65 score guides CAP management: score ≥3 requires hospital admission
  • FeverPAIN score guides sore throat prescribing: score 4–5 warrants immediate antibiotics
  • Never treat asymptomatic bacteriuria in catheterised patients
  • Always document antibiotic indication, dose, duration, and review date
Topics:AntibioticsAntimicrobial StewardshipUTIRTINICEResistance